Differential p38-dependent signalling in response to cellular stress and mitogenic stimulation in fibroblasts

Cell Communication and Signaling

Volumn 10, Issue , 2012, Pages

  Faust, Dagmar ^a   Schmitt, Christina ^a   Oesch, Franz ^a   Oesch Bartlomowicz, Barbara ^a   Schreck, Ilona ^b   Weiss, Carsten ^b   Dietrich, Cornelia ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Cellular stress; Fibroblasts; Mitogens; p38 MAPK; Signalling

Indexed keywords

ANISOMYCIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGENIC AGENT; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FIBROBLAST; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

EID: 84861179304     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-10-6     Document Type: Article

References (66)

1. Protein kinase cascades activated by stress and inflammatory cytokines. Kyriakis J, Avruch J, Bioessays 1996 18 567 577 10.1002/bies.950180708 8757935 (Pubitemid 26311096)
2. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. Junttila MR, Li S-P, Westermarck J, FASEB J 2008 22 954 964 18039929
3. Supreme EnLIGHTenment: damage recognition and signaling in the mammalian UV response. Herrlich P, Karin M, Weiss C, Mol Cell 2008 29 279 290 10.1016/j.molcel.2008.01.001 18280234 (Pubitemid 351215936)
4. Mechanisms and functions of p38 MAPK signalling. Cuadrado A, Nebreda AR, Biochem J 2010 429 403 417 10.1042/BJ20100323 20626350
5. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Han J, Lee J-D, Bibbs L, Ulevitch RJ, Science 1994 265 808 811 10.1126/science.7914033 7914033 (Pubitemid 24266145)
6. The pathways to tumor suppression via route p38. Han J, Sun P, Trends Biochem Sci 2007 32 364 371 10.1016/j.tibs.2007.06.007 17624785 (Pubitemid 47126858)
7. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Wang XZ, Ron D, Science 1996 272 1347 1349 10.1126/science.272.5266.1347 8650547 (Pubitemid 26199977)
8. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. Kim JY, Choi JA, Kim TH, Yoo YD, Kim JI, Lee YJ, Yoo SY, Cho CK, Lee YS, Lee SJ, J Cell Physiol 2002 190 29 37 10.1002/jcp.10049 11807808 (Pubitemid 33116288)
9. The p38 pathway provides negative feedback for Ras proliferative signaling. Chen G, Hitomi M, Han J, Stacey DW, J Biol Chem 2000 275 38973 38980 10.1074/jbc.M002856200 10978313 (Pubitemid 32058908)
10. Cdc42Hs, but not rac1, inhibits serum- stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. Molnar A, Theodoras A, Zon L, Kyriakis J, J Biol Chem 1997 272 13229 13235 10.1074/jbc.272.20.13229 9148940 (Pubitemid 27216750)
11. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, Wang JYJ, Genes Dev 2011 14 574 584
12. p38alpha MAPK is required for contact inhibition. Faust D, Dolado I, Cuadrado A, Oesch F, Weiss C, Nebreda AR, Dietrich C, Oncogene 2005 24 7941 7945 10.1038/sj.onc.1208948 16027723 (Pubitemid 41715200)
13. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. Maher P, J Biol Chem 1999 274 17491 17498 10.1074/jbc.274.25. 17491 10364180 (Pubitemid 29283257)
14. Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase. Dixon M, Agius L, Yeaman SJ, Day CP, Hepatology 1999 29 1418 1424 10.1002/hep.510290516 10216124 (Pubitemid 29211042)
15. Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation. Rausch O, Marshall C, J Biol Chem 1999 274 4096 4105 10.1074/jbc.274.7.4096 9933603 (Pubitemid 29090937)
16. Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Chen L, Mayer JA, Krisko TI, Speers CW, Wang T, Hilsenbeck SG, Brown PH, Cancer Res 2009 69 8853 8861 10.1158/0008-5472.CAN-09- 1636 19920204
17. p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation. Halawani D, Mondeh R, Stanton LA, Beier F, Oncogene 2004 23 3726 3731 10.1038/sj.onc.1207422 15116104 (Pubitemid 38658441)
18. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Recio JA, Merlino G, Oncogene 2002 21 1000 1008 10.1038/sj.onc.1205150 11850817 (Pubitemid 34174512)
19. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. Cuenda A, Rouse J, Doza Y, Meier R, Cohen P, Gallagher T, Young P, Lee J, FEBS Lett 1995 364 229 233 10.1016/0014-5793(95)00357-F 7750577
20. The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cells. Behren A, Binder K, Vucelic G, Herberhold S, Hirt B, Loewenheim H, Preyer S, Zenner HP, Simon C, Exp Cell Res 2005 303 321 330 10.1016/j.yexcr.2004.10.004 15652346 (Pubitemid 40126266)
21. The selectivity of protein kinase inhibitors: a further update. Bain J, Plater L, Elliot M, Shpiro N, Hastie J, McLaughlan H, Klevernic I, Arthur JSC, Alessi DR, Cohen P, Biochem J 2007 408 297 315 10.1042/BJ20070797 17850214
22. MKK3- and MKK6- regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Raingeaud J, Whitmarsh A, Barrett T, Derijard B, Davis R, Mol Cell Biol 1996 16 1247 1255 8622669
23. The p38 signal transduction pathway Activation and function. Ono K, Han J, Cell Signal 2000 12 1 13 10.1016/S0898-6568(99)00071-6 10676842 (Pubitemid 30017963)
24. Mammalian cyclin-dependent kinases. Malumbres M, Barbacid M, Trends Biochem Sci 2005 30 630 641 10.1016/j.tibs.2005.09.005 16236519 (Pubitemid 41540083)
25. Pro- inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. Raingeaud J, Gupta S, Rogers J, Dickens M, Han J, Ulevitch RJ, Davis R, J Biol Chem 1995 270 7420 7426 10.1074/jbc.270.13.7420 7535770
26. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. Deak M, Clifton A, Lucocq J, Alessi D, EMBO J 1998 17 4426 4441 10.1093/emboj/17.15.4426 9687510 (Pubitemid 28362632)
27. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP-K2. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb M, EMBO J 1996 15 4629 4642 8887554 (Pubitemid 26294581)
28. CREB is activated by UVC through a p38/HOG-1- dependent protein kinase. Iordanov M, Bender K, Ade T, Schmid W, Sachsenmaier C, Engel K, Gaestel M, Rahmsdorf HJ, Herrlich P, EMBO J 1997 16 1009 1022 10.1093/emboj/16.5.1009 9118940 (Pubitemid 27113180)
29. Rho proteins: targets for bacterial toxins. Aktories K, TiMB 1997 5 282 288 (Pubitemid 27314517)
30. Bacterial cytotoxins: targeting eukaryotic switches. Aktories K, Barbieri JT, Nat Rev Microbiol 2005 3 397 410 10.1038/nrmicro1150 15821726 (Pubitemid 40590382)
31. Bacterial toxins that modify the actin cytoskeleton. Barbieri JT, Riese MJ, Aktories K, Annu Rev Cell Dev Biol 2002 18 315 344 10.1146/annurev.cellbio. 18.012502.134748 12142277 (Pubitemid 35387354)
32. Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. Popoff MR, Chaves-Olarte E, Lemichez E, von Eichel-Streiber C, Thelestam M, Chardin P, Cussac D, Antonny B, Chavrier P, Flatau G, Giry M, de Gunzburg J, Boquet P, J Biol Chem 1996 271 10217 10224 10.1074/jbc.271.17.10217 8626586 (Pubitemid 26131588)
33. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Marshall C, Cell 1995 80 179 185 10.1016/0092-8674(95)90401-8 7834738
34. pp 60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GK, Webster M, Muller WJ, Brugge JS, Davis RJ, Pestell RG, J Biol Chem 1999 274 7341 7350 10.1074/jbc.274.11.7341 10066798 (Pubitemid 29140552)
35. ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Villanueva J, Yung Y, Walker JL, Assoian RK, Mol Biol Cell 2007 18 1457 1463 10.1091/mbc.E06-10-0908 17314399 (Pubitemid 46626640)
36. Sequential activation of the MEK-extracellular signal-related kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Wang W, Chen JX, Liao R, Deng Q, Zhou J, Huang S, Sun P, Mol Cell Biol 2002 22 2289 3403
37. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Iwasa H, Han J, Ishikawa F, Genes Cells 2003 8 131 144 10.1046/j.1365-2443.2003.00620.x 12581156 (Pubitemid 36511698)
38. Phenotype-assisted transcriptome analysis identifies foxm1 downstream from ras-MKK3-p38 to regulate in vitro cellular invasion. Behren A, Mühlen S, Acuna Sanhueza GA, Schwager C, Plinkert PK, Huber PE, Abdollahi A, Simon C, Oncogene 2010 29 1519 1530 10.1038/onc.2009.436 20023695
39. Wild-type p53 protects normal cells against apoptosis induced by thiostrepton. Halasi M, Schraufnagel DP, Gartel AL, Cell Cycle 2009 8 2850 2851 10.4161/cc.8.17.9414 19652535
40. p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells. Bhana S, Hewer A, Phillips DH, Lloyd DR, Mutagenesis 2008 23 131 136 10.1093/mutage/gen001 18267949
41. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-jun/ATF-2 phosphorylation are insufficient. Hazzalin C, Cano E, Cuenda A, Barratt M, Cohen P, Mahadevan L, Curr Biol 1996 6 1028 1031 10.1016/S0960- 9822(02)00649-8 8805335 (Pubitemid 26350724)
42. p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O, Nebreda AR, Mol Cell Biol 2009 29 4341 4351 10.1128/MCB.00210-09 19528229
43. p27Kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage. Cuadrado M, Gutierrez-Martinez P, Swat A, Nebreda AR, Fernandez-Capetillo O, Cancer Res 2009 69 8726 8732 10.1158/0008-5472.CAN-09-0729 19843869
44. Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation. Swat A, Dolado I, Rojas JM, Nebreda AR, Mol Cell Biol 2009 29 3332 3343 10.1128/MCB.01955-08 19364817
45. Autophagy regulates ROS-induced cellular senescence via p21 in a p38 MAPK dependent manner. Luo Y, Zou P, Zou J, Wang J, Zhou D, Liu L, Exp Gerontol 2011 46 860 867 10.1016/j.exger.2011.07.005 21816217
46. Stress responses of human dermal fibroblasts exposed to zinc pyrithione. Rudolf E, Cervinka M, Toxicol Lett 2011 204 164 173 10.1016/j.toxlet.2011.04.028 21557991
47. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor- suppressing function of stress-activated mitogen-activated protein kinase. Nakagawa H, Hirata Y, Takeda K, Hayakawa Y, Sato T, Kinoshita H, Sakamoto K, Nakata W, Hikiba Y, Omata M, Yoshida H, Koike K, Ichijo H, Maeda S, Hepatology 2011 54 185 195 10.1002/hep.24357 21488081
48. Reactive oxygen species and hematopoietic stem cell senescence. Shao L, Li H, Pazhanisamy SK, Meng A, Wang Y, Zhou D, Int J Hematol 2011 94 24 32 10.1007/s12185-011-0872-1 21567162
49. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras- induced premature senescence. Li H, Wang W, Liu X, Paulson KE, Yee AS, Zhang X, Oncogene 2010 29 5083 5094 10.1038/onc.2010.252 20581871
50. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. Kwong J, Hong L, Liao R, Deng Q, Han J, Sun P, J Biol Chem 2009 284 11237 11246 19251701
51. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E, Fornace AJ Jr, Nat Genet 2004 36 343 350 10.1038/ng1317 14991053 (Pubitemid 38437256)
52. Differential response of nucleus pulposus intervertebral disc cells to high salt, sorbitol and urea. Mavrogonatou E, Kletsas D, J Cell Physiol 2011 doi:10.1002/jcp.22840
53. Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: short- and long-term exposure affect proliferation and neuroendocrine differentiation. Farini D, Puglianiello A, Mammi C, Siracusa G, Moretti C, Endocrinology 2003 144 1631 1643 10.1210/en.2002-221009 12639948 (Pubitemid 36428506)
54. Cell cycle arrest induced by the bacterial adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Gray MC, Hewlett EL, Cell Microbiol 2011 131 123 134
55. Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Li Y, Yin W, Wang X, Zhu W, Huang Y, Yan G, Proc Natl Acad Sci USA 2007 104 13438 13443 10.1073/pnas.0701990104 17679696 (Pubitemid 47293963)
56. p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Shen G, Xu C, Chen C, Hebbar V, Kong AN, Cancer Chemother Pharmacol 2006 57 317 327 10.1007/s00280-005-0050-3 16170570
57. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P, EMBO J 1995 14 1798 1811 7737130
58. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. Cavigelli M, Li W, Lin A, Su B, Yoshioka K, Karin M, EMBO J 1996 15 6269 6279 8947050 (Pubitemid 26397900)
59. Signaling from G protein-coupled receptors to c-jun kinase involves bg subunits or heterotrimeric G proteins acting on a ras and rac1-dependent pathway. Coso O, Teramoto H, Simonds W, Gutkind JS, J Biol Chem 1995 271 3963 3966 (Pubitemid 26070490)
60. Neosynthesis and activation of rho by Escherichia coli cytotoxic necrotizing factor (CNF1) reverse cytopathic effects of ADP-ribosylated rho. Barth H, Olenik C, Sehr P, Schmidt G, Aktories K, Meyer DK, J Biol Chem 1999 274 27407 27414 10.1074/jbc.274.39.27407 10488072 (Pubitemid 29457980)
61. Cdc42 and PAK-mediated signaling leads to jun kinase and p38 mitogen-activated protein kinase activation. Bagrodia S, Derijard B, Davis R, Cerione R, J Biol Chem 1995 270 27995 27998 10.1074/jbc.270.47.27995 7499279
62. Selective activation of the JNK signaling cascade and c-jun transcriptional activity by the small GTPases rac and cdc42Hs. Minden A, Lin A, Claret F-X, Abo A, Karin M, Cell 1995 81 1147 1157 10.1016/S0092-8674(05)80019-4 7600582
63. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Dietrich C, Wallenfang K, Oesch F, Wieser R, Oncogene 1997 15 2743 2747 10.1038/sj.onc.1201439 9401001 (Pubitemid 27507622)
64. p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L- norleucinal in platelet-derived growth factor stimulated human fibroblasts. Dietrich C, Bartsch T, Schanz F, Oesch F, Wieser R, Proc Natl Acad Sci USA 1996 93 10815 10819 10.1073/pnas.93.20.10815 8855263 (Pubitemid 26333072)
65. Measurement of protein using bicinchoninic acid. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC, Anal Biochem 1985 150 76 78 10.1016/0003-2697(85)90442-7 3843705 (Pubitemid 16258399)
66. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Weiss C, Faust D, Dürk H, Kolluri SK, Pelzer A, Schneider S, Dietrich C, Oesch F, Göttlicher M, Oncogene 2005 24 4975 4983 10.1038/sj.onc.1208679 15897893 (Pubitemid 41129101)